Long-Term Effects of Weight Loss and Exercise on Biomarkers Associated with Angiogenesis
Overview
Oncology
Public Health
Affiliations
We tested the effect of weight loss on circulating levels of the angiogenic factors VEGF and pigment epithelium-derived factor (PEDF) in postmenopausal overweight/obese women, 18 months after completing a year-long 4-arm randomized controlled trial of behavioral weight loss and/or exercise versus control (i.e., 30 months postrandomization). The 439 overweight/obese, postmenopausal women, ages 50 to 75 years, were randomized to: diet (goal: 10% weight loss, = 118), exercise (225 min/wk moderate-to-vigorous activity, = 117), diet + exercise ( = 117), or control ( = 87). At 12 months, 399 women gave a blood sample; 156 returned at 30 months. Biomarkers were measured by immunoassay. Changes were compared using generalized estimating equations, adjusting for baseline BMI, age, and race/ethnicity. Participants randomized to diet, exercise, and diet + exercise arms had greater reductions in VEGF at 30 months (-14.1% = 0.02; -19.7% = 0.003; -14.5% = 0.002, respectively) versus controls (-4.5%). There were no statistically significant changes in PEDF in any intervention arm. Participants maintaining ≥10% of baseline weight loss at 30 months had greater reductions in VEGF versus those who gained weight/had no weight change (-22.3% vs. -10.2% respectively, = 0.002). Participants maintaining any weight loss had significantly lower levels of PEDF at 30 months versus those who gained weight/no weight change. Sustained weight loss via diet and/or exercise results in reductions in angiogenic factors, and can be maintained up to 30-month follow-up. Limitations include relatively small numbers, and possible bias toward more successful weight loss among women who returned at 30 months. Maintaining weight loss can achieve long-term reductions in biomarkers of angiogenesis that can persist up to 18 months after completion of a weight loss intervention. .
Wang H, Cheng R, Xie L, Hu F Front Endocrinol (Lausanne). 2024; 14:1294362.
PMID: 38288474 PMC: 10823366. DOI: 10.3389/fendo.2023.1294362.
Espeland M, Evans J, Carmichael O, Luchsinger J, Marcovina S, Neiberg R Obesity (Silver Spring). 2022; 30(9):1863-1874.
PMID: 35920161 PMC: 9420754. DOI: 10.1002/oby.23495.
Quantile-specific heritability of serum growth factor concentrations.
Williams P Growth Factors. 2022; 39(1-6):45-58.
PMID: 35312415 PMC: 10101221. DOI: 10.1080/08977194.2022.2049261.
Adipose endothelial cells mastering adipose tissues metabolic fate.
Liao Z, Ran L, Qi X, Wang Y, Wang Y, Yang J Adipocyte. 2022; 11(1):108-119.
PMID: 35067158 PMC: 8786343. DOI: 10.1080/21623945.2022.2028372.
Wood G, Bailey-Davis L, Benotti P, Cook A, Dove J, Mowery J PLoS One. 2021; 16(11):e0258545.
PMID: 34731171 PMC: 8565747. DOI: 10.1371/journal.pone.0258545.